MarketCapTrends
CPRX

Catalyst Pharmaceuticals Inc. (CPRX)

NASDAQ · Healthcare

Catalyst Pharmaceuticals Inc. annual/quarterly total liabilities history from 2012 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Catalyst Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 149.7M, a 20.95% increase year-over-year.
  • Catalyst Pharmaceuticals Inc. total liabilities for 2025 were 149.7M, a 20.95% increase from 2024.
  • Catalyst Pharmaceuticals Inc. total liabilities for 2024 were 123.8M, a 50.52% increase from 2023.
  • Catalyst Pharmaceuticals Inc. total liabilities for 2023 were 82.2M, a 9.34% increase from 2022.
  • Catalyst Pharmaceuticals Inc. total liabilities for 2022 were 75.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Catalyst Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$150
2024$124
2023$82
2022$75
2021$31
2020$23
2019$25
2018$10
2017$4
2016$2
2015$5
2014$9
2013$4
2012$2
Catalyst Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$150
2024-12-31$124
2023-12-31$82
2022-12-31$75
2021-12-31$31
2020-12-31$23
2019-12-31$25
2018-12-31$10
2017-12-31$4
2016-12-31$2
2015-12-31$5
2014-12-31$9
2013-12-31$4
2012-12-31$2

Catalyst Pharmaceuticals Inc. Total Liabilities — FAQ

Catalyst Pharmaceuticals Inc. (CPRX) total liabilities over the last 14 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CPRX's total liabilities history?

The chart and table above show Catalyst Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.